5-[3-(3-bromophenyl)-1,2,4-oxadiazol-5-yl]-1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-1,2-dihydropyridin-2-one
5-[3-(3-溴苯基)-1,2,4-噁二唑-5-基]-1-[2-(2,3-二氢-1H-吲哚-1-基)-2-氧代乙基]-1,2-二氢吡啶-2-酮
5-[3-(3-bromophenyl)-1,2,4-oxadiazol-5-yl]-1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-1,2-dihydropyridin-2-one (CAS 1326871-71-9) is a compound in the Pharma Intermediates category listed in the Jingsj chemical database. It has the molecular formula C23H17BrN4O3 and a molecular weight of 477.3 g/mol. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.
- CAS No.
- 1326871-71-9
- Jingsj CID
- J-1343027-0
- Molecular Formula
- C23H17BrN4O3
- Chinese Name
- 5-[3-(3-溴苯基)-1,2,4-噁二唑-5-基]-1-[2-(2,3-二氢-1H-吲哚-1-基)-2-氧代乙基]-1,2-二氢吡啶-2-酮
- Molecular Weight
- 477.3 g/mol
- Category
- Pharma Intermediates
- Last updated
- 8/21/2026
No offers for this compound yet.
Request a quoteFrequently Asked Questions
What is the CAS number of 5-[3-(3-bromophenyl)-1,2,4-oxadiazol-5-yl]-1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-1,2-dihydropyridin-2-one?
The CAS number of 5-[3-(3-bromophenyl)-1,2,4-oxadiazol-5-yl]-1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-1,2-dihydropyridin-2-one is 1326871-71-9.
What are the molecular formula and molecular weight of 5-[3-(3-bromophenyl)-1,2,4-oxadiazol-5-yl]-1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-1,2-dihydropyridin-2-one?
5-[3-(3-bromophenyl)-1,2,4-oxadiazol-5-yl]-1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-1,2-dihydropyridin-2-one has molecular formula C23H17BrN4O3 and molecular weight 477.3 g/mol.
Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.
Last updated:
How to cite: Jingsj. "5-[3-(3-bromophenyl)-1,2,4-oxadiazol-5-yl]-1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-1,2-dihydropyridin-2-one (CAS 1326871-71-9)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1343027-0 (accessed 2026-10-25).
Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.